MEDIA News Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium August 4, 2025 Read » Cresilon Announces International Distribution Agreement for VETIGEL with McCarthy Vet June 16, 2025 Read » Cresilon Announces U.S. Nationwide Launch of TRAUMAGEL January 13, 2025 Read » Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell VETIGEL® Hemostatic Gel in the Animal Health Market January 7, 2025 Read » The Dave Crenshaw Success Show – The Lifesaving Inventor, Joe Landolina October 21, 2024 Read » Cresilon Selected to Exhibit TRAUMAGEL at Vizient Innovative Technology Exchange September 16, 2024 Read » Cresilon Receives FDA Clearance for TRAUMAGEL August 15, 2024 Read » Cresilon’s Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research July 9, 2024 Read » Cresilon Announces Preferred Partnership Agreement for VETIGEL with VerticalVet June 11, 2024 Read » Fast Company: Stopping bleeding instantly May 23, 2024 Read » Grow Everything Podcast – At The Bleeding Edge May 20, 2024 Read » Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus May 20, 2024 Read » Cresilon Named Most Innovative Company of the Year May 6, 2024 Read » VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services April 24, 2024 Read » Cresilon Announces Distribution Partnerships for VETIGEL with Leading Animal Health and Veterinary Product Suppliers April 18, 2024 Read » This company’s hummus-colored gel could change how doctors stop bleeding March 19, 2024 Read » Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need March 15, 2024 Read » Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply August 22, 2023 Read » An Unorthodox Path to Medical Device Success July 25, 2023 Read » Med Tech Gurus Podcast July 25, 2023 Read » Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology June 28, 2023 Read » Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market October 27, 2022 Read » Cresilon and Walter Reed Army Institute of Research Sign Cooperative R&D Agreement for Treatment of Traumatic Brain Injuries September 27, 2022 Read » Hemostatic Gel Immediately Stops Multiple Types of Bleeds Without Need to Apply Pressure August 22, 2022 Read » Stopping Bleeding with Algal-Based Polymers April 11, 2022 Read » Interview: 17-year-old invents life-saving gel technology April 11, 2022 Read » Cresilon Announces FDA 510(k) Submission For Human Use Hemostatic Gel Technology November 30, 2021 Read » Brooklyn Heights native’s company Cresilon creates gel to stop bleeding October 28, 2021 Read » Cresilon Closes $38.5 Million Series A-3 Financing to Accelerate Commercialization of Hemostatic Gel September 30, 2021 Read » Subscribe to our Newsletter Stay in touch with us to get Cresilon’s news, investment opportunities, and product releases. Address 86 34th Street, Suite D603/D604, Brooklyn, NY 11232 Call Us (347) 435-2226 Email Us info@cresilon.com
Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium August 4, 2025 Read »
Cresilon Announces International Distribution Agreement for VETIGEL with McCarthy Vet June 16, 2025 Read »
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell VETIGEL® Hemostatic Gel in the Animal Health Market January 7, 2025 Read »
Cresilon Selected to Exhibit TRAUMAGEL at Vizient Innovative Technology Exchange September 16, 2024 Read »
Cresilon’s Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research July 9, 2024 Read »
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus May 20, 2024 Read »
VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services April 24, 2024 Read »
Cresilon Announces Distribution Partnerships for VETIGEL with Leading Animal Health and Veterinary Product Suppliers April 18, 2024 Read »
Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need March 15, 2024 Read »
Cresilon Announces Distribution Agreement for VETIGEL with Penn Veterinary Supply August 22, 2023 Read »
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology June 28, 2023 Read »
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market October 27, 2022 Read »
Cresilon and Walter Reed Army Institute of Research Sign Cooperative R&D Agreement for Treatment of Traumatic Brain Injuries September 27, 2022 Read »
Hemostatic Gel Immediately Stops Multiple Types of Bleeds Without Need to Apply Pressure August 22, 2022 Read »
Cresilon Announces FDA 510(k) Submission For Human Use Hemostatic Gel Technology November 30, 2021 Read »
Cresilon Closes $38.5 Million Series A-3 Financing to Accelerate Commercialization of Hemostatic Gel September 30, 2021 Read »